3382:TSESeven & I Holdings Co., Ltd. Analysis
Data as of 2026-03-10 - not real-time
¥2,055.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Seven & i Holdings trades around ¥2,055, well above its DCF‑derived fair value of roughly ¥1,240, suggesting the market is pricing in optimism despite a 20% revenue contraction and a hefty debt‑to‑equity ratio of 104%. The stock’s technical profile is mixed: RSI sits at 36, hinting at near‑oversold conditions, while the MACD remains bearish and the 20‑day SMA (¥2,203) sits above the current price, reinforcing a neutral‑to‑downward bias. Recent earnings releases show a striking 324% YoY EPS jump and a 3.1% rise in operating income, beating consensus forecasts and fueling short‑term enthusiasm. However, free cash flow is negative and leverage is high, raising questions about the sustainability of the 2.42% dividend (payout ~48%).
The defensive grocery sector generally offers low‑volatility exposure (beta ~0.13, 30‑day volatility 27.8%), but Seven & i’s international footprint adds medium geographic risk and modest currency exposure. Valuation metrics (PE 21.8x, forward PE 17.8x) appear stretched relative to earnings growth, and the “Extreme Greed” sentiment index (78.8) may be over‑optimistic. In sum, the stock shows short‑term upside potential from earnings momentum but faces longer‑term headwinds from weak cash generation, high debt, and an overvalued price.
The defensive grocery sector generally offers low‑volatility exposure (beta ~0.13, 30‑day volatility 27.8%), but Seven & i’s international footprint adds medium geographic risk and modest currency exposure. Valuation metrics (PE 21.8x, forward PE 17.8x) appear stretched relative to earnings growth, and the “Extreme Greed” sentiment index (78.8) may be over‑optimistic. In sum, the stock shows short‑term upside potential from earnings momentum but faces longer‑term headwinds from weak cash generation, high debt, and an overvalued price.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Recent earnings beat and 324% EPS surge
- RSI near oversold levels offering bounce potential
- Bearish MACD and price below 20‑day SMA limiting upside
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Current price above DCF fair value indicating overvaluation
- Revenue decline and high leverage constraining growth
- Stable dividend yield but questionable cash sustainability
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Persistent revenue contraction and negative free cash flow
- Debt‑to‑equity over 100% raising solvency concerns
- Valuation metrics remain stretched relative to fundamentals
Key Metrics & Analysis
Financial Health
Revenue Growth-20.70%
Profit Margin3.29%
P/E Ratio21.8
ROE8.58%
ROA2.72%
Debt/Equity104.41
P/B Ratio1.4
Op. Cash Flow¥609.0B
Free Cash Flow¥-464384262144
Technical Analysis
TrendNeutral
RSI36.5
Support¥1,981.00
Resistance¥2,417.00
MA 20¥2,203.00
MA 50¥2,229.18
MA 200¥2,117.84
MACDBearish
VolumeIncreasing
Fear & Greed Index78.79
Valuation
Fair Value¥1,238.81
Target Price¥2,460.67
Upside/Downside19.74%
GradeOvervalued
TypeBlend
Dividend Yield2.42%
Risk Assessment
Beta0.40
Volatility27.76%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.